Sex Differences in Risk Factor Management of Coronary Heart Disease Across Three Regions

Overview

Journal Heart

Date 2017 Sep 22

PMID 28931567

Citations 49

Authors

Min Zhao

Ilonca Vaartjes

Ian Graham

Diederick Grobbee

Wilko Spiering

Kerstin Klipstein-Grobusch

Mark Woodward

Sanne Ae Peters

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate whether there are sex differences in risk factor management of patients with established coronary heart disease (CHD), and to assess demographic variations of any potential sex differences.

Methods: Patients with CHD were recruited from Europe, Asia, and the Middle East between 2012-2013. Adherence to guideline-recommended treatment and lifestyle targets was assessed and summarised as a Cardiovascular Health Index Score (CHIS). Age-adjusted regression models were used to estimate odds ratios for women versus men in risk factor management.

Results: 10 112 patients (29% women) were included. Compared with men, women were less likely to achieve targets for total cholesterol (OR 0.50, 95% CI 0.43 to 0.59), low-density lipoprotein cholesterol (OR 0.57, 95% CI 0.51 to 0.64), and glucose (OR 0.78, 95% CI 0.70 to 0.87), or to be physically active (OR 0.74, 95% CI 0.68 to 0.81) or non-obese (OR 0.82, 95% CI 0.74 to 0.90). In contrast, women had better control of blood pressure (OR 1.31, 95% CI 1.20 to 1.44) and were more likely to be a non-smoker (OR 1.93, 95% CI 1.67 to 2.22) than men. Overall, women were less likely than men to achieve all treatment targets (OR 0.75, 95% CI 0.60 to 0.93) or obtain an adequate CHIS (OR 0.81, 95% CI 0.73 to 0.91), but no significant differences were found for all lifestyle targets (OR 0.93, 95% CI 0.84 to 1.02). Sex disparities in reaching treatment targets were smaller in Europe than in Asia and the Middle East. Women in Asia were more likely than men to reach lifestyle targets, with opposing results in Europe and the Middle East.

Conclusions: Risk factor management for the secondary prevention of CHD was generally worse in women than in men. The magnitude and direction of the sex differences varied by region.

Citing Articles

Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women.

van Oortmerssen J, Mulder J, van der Bijl M, Mijnster R, Kavousi M, Roeters van Lennep J Curr Atheroscler Rep. 2025; 27(1):29.

PMID: 39873822 PMC: 11775078. DOI: 10.1007/s11883-025-01275-1.

Demographic Predictors of Elevated LDL Cholesterol in Type 1 Diabetes: A Cross-Sectional Study.

Dart M, Patrie J, Love K Clin Diabetes. 2025; 43(1):92-99.

PMID: 39829709 PMC: 11739341. DOI: 10.2337/cd24-0051.

Sex-specific mechanisms in vascular aging: exploring cellular and molecular pathways in the pathogenesis of age-related cardiovascular and cerebrovascular diseases.

Ungvari A, Gulej R, Patai R, Papp Z, Toth A, Szabo A Geroscience. 2025; 47(1):301-337.

PMID: 39754010 PMC: 11872871. DOI: 10.1007/s11357-024-01489-2.

Trajectories and management of vascular risk following the diagnosis of multiple sclerosis: A population-based matched cohort study between 1987 and 2018 in England.

Palladino R, Chataway J, Mathew M, Majeed A, Marrie R Mult Scler. 2024; 30(13):1653-1663.

PMID: 39420581 PMC: 11568649. DOI: 10.1177/13524585241287388.

Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysis.

Cherla A, Kyriopoulos I, Pearcy P, Tsangalidou Z, Hajrulahovic H, Theodorakis P Lancet Reg Health Eur. 2024; 47:101079.

PMID: 39397877 PMC: 11470399. DOI: 10.1016/j.lanepe.2024.101079.

References

Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K . Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart. 2010; 96(21):1744-9. DOI: 10.1136/hrt.2010.196170. View

Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C . EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2015; 23(6):636-48. DOI: 10.1177/2047487315569401. View

Blomkalns A, Chen A, Hochman J, Peterson E, Trynosky K, Diercks D . Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early.... J Am Coll Cardiol. 2005; 45(6):832-7. DOI: 10.1016/j.jacc.2004.11.055. View

Victor B, Teal V, Ahedor L, Karalis D . Gender differences in achieving optimal lipid goals in patients with coronary artery disease. Am J Cardiol. 2014; 113(10):1611-5. DOI: 10.1016/j.amjcard.2014.02.018. View

Dewilde S, Carey I, Richards N, Whincup P, Cook D . Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart. 2007; 94(1):83-8. DOI: 10.1136/hrt.2006.111757. View

Virani S, Woodard L, Ramsey D, Urech T, Akeroyd J, Shah T . Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2014; 115(1):21-6. DOI: 10.1016/j.amjcard.2014.09.041. View

Mosca L, Barrett-Connor E, Wenger N . Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011; 124(19):2145-54. PMC: 3362050. DOI: 10.1161/CIRCULATIONAHA.110.968792. View

De Smedt D, De Bacquer D, De Sutter J, Dallongeville J, Gevaert S, De Backer G . The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology. Int J Cardiol. 2016; 209:284-90. DOI: 10.1016/j.ijcard.2016.02.015. View

Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Atherosclerosis. 2016; 252:207-274. DOI: 10.1016/j.atherosclerosis.2016.05.037. View

10.

Ramachandran H, Wu V, Kowitlawakul Y, Wang W . Awareness, knowledge and healthy lifestyle behaviors related to coronary heart disease among women: An integrative review. Heart Lung. 2016; 45(3):173-85. DOI: 10.1016/j.hrtlng.2016.02.004. View

11.

Shah T, Palaskas N, Ahmed A . An Update on Gender Disparities in Coronary Heart Disease Care. Curr Atheroscler Rep. 2016; 18(5):28. DOI: 10.1007/s11883-016-0574-5. View

12.

Lloyd-Jones D, Hong Y, Labarthe D, Mozaffarian D, Appel L, Van Horn L . Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010; 121(4):586-613. DOI: 10.1161/CIRCULATIONAHA.109.192703. View

13.

Mosca L, Mochari H, Christian A, Berra K, Taubert K, Mills T . National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation. 2006; 113(4):525-34. DOI: 10.1161/CIRCULATIONAHA.105.588103. View

14.

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted.... Eur Heart J. 2012; 33(13):1635-701. DOI: 10.1093/eurheartj/ehs092. View

15.

Maas A, van der Schouw Y, Regitz-Zagrosek V, Swahn E, Appelman Y, Pasterkamp G . Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J. 2011; 32(11):1362-8. DOI: 10.1093/eurheartj/ehr048. View

16.

Koopman C, Vaartjes I, Heintjes E, Spiering W, van Dis I, Herings R . Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010. Eur Heart J. 2013; 34(41):3198-205. DOI: 10.1093/eurheartj/eht368. View

17.

Mosca L, Mochari-Greenberger H, Dolor R, Newby L, Robb K . Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010; 3(2):120-7. PMC: 2956447. DOI: 10.1161/CIRCOUTCOMES.109.915538. View

18.

. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1459-1544. PMC: 5388903. DOI: 10.1016/S0140-6736(16)31012-1. View

19.

Cooney M, Reiner Z, Sheu W, Ryden L, De Sutter J, De Bacquer D . SURF - SUrvey of Risk Factor management: first report of an international audit. Eur J Prev Cardiol. 2012; 21(7):813-22. DOI: 10.1177/2047487312467870. View

20.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View